Follow-up: HNSN upgraded to Buy from Accumulate@THNK ThinkEquity believes HNSN has a good chance of imitating ISRG's business model, the CFO is a co-founder of ISRG, and that the St. Jude partnership is highly valuable in both near-term system sales and could result in an acquisition over the long term. Target to $32 from $20.